Statistics

Statistics

Total Visits

Views
A randomized, open-label, phase II study of lapatinib/capecitabine, lapatinib/vinorelbine, or lapatinib/gemcitabine in patients with ErbB2-amplified metastatic breast cancer progressing after taxane treatment: Results of an interim analysis (GLICO-0801/EGF111792) 1

Total Visits Per Month

January 2019 February 2019 March 2019 April 2019 May 2019 June 2019 July 2019
A randomized, open-label, phase II study of lapatinib/capecitabine, lapatinib/vinorelbine, or lapatinib/gemcitabine in patients with ErbB2-amplified metastatic breast cancer progressing after taxane treatment: Results of an interim analysis (GLICO-0801/EGF111792) 1 0 0 0 0 0 0

Top country views

Views

Top cities views

Views

Search DSpace



Browse

My Account

Statistics